HealthQuill Drugs
Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of 30%, according to a Securities and Exchange Commission filing.
Drugs Medical Pharma

Biogen Inc., to buy 62m outstanding shares of Sage for $441.7 million

Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of.

Read More
US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which is under trial, for treating chronic kidney diseases.
Drugs Health Pharma

Vertex, China’s Zai to develop, commercialise kidney disease drug

US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which.

Read More
Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained free of complications, according to a company statement.
Drugs Health Medical

Pfizer’s trial antibody for type of bladder cancer meets main goal

Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained.

Read More
Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University of Cambridge and Fudan University involving 42,000 adults.
Drugs Health Research

Effects of loneliness, social isolation leave their mark on blood: Cambridge study

Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University.

Read More
China has approved Merck & Co.’s human papillomavirus vaccine for males between nine and 26 years amid a fall in sales for the jab among women in the world’s most populous country, according to a company statement.
Drugs Health Medical

China approves Merck’s human papillomavirus jab for use in males 

China has approved Merck & Co.’s human papillomavirus vaccine for males between nine and 26 years amid a fall in sales for the.

Read More
Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs to be jointly developed, according to a statement.
Drugs Health Medical

Novo Nordisk, Valo expand pact to include obesity, diabetic drugs

Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.

Read More
A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World Health Organization has not observed “unusual outbreak patterns.”
Drugs Health Medical

Respiratory infections in China have no ‘unusual outbreak patterns’

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World.

Read More
Johnson & Johnson’s combination therapy for treating a certain form of cancer without chemotherapy, has been shown to extend patients' lives by more than a year, according to a company statement.
Drugs Health Medical Pharma

J&J’s combination extends lives of cancer patients versus rival drug

Johnson & Johnson’s combination therapy for treating a certain form of cancer without chemotherapy, has been shown to extend patients' lives by more.

Read More
Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to an observational study on 23 patients conducted by Canada’s York University.
Drugs Health Medical

Dancing can help lower depression in people with Parkinson’s disease

Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to.

Read More
China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight cancer for an upfront payment of $925 million.
Drugs Medical Pharma

WuXi Biologics sells global rights to cancer antibody to Candid for $925m

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.

Read More